Great Point Partners, Dr. Jay & Nordahl disclose 8.45% stake in Sol-Gel (SLGL)
Great Point Partners, LLC, Dr. Jeffrey R. Jay, and Ms. Lillian Nordahl have disclosed an 8.45% beneficial ownership stake in Sol-Gel Technologies Ltd. (SLGL). This stake, totaling 274,363 ordinary shares, is reported in a Schedule 13G filing. The percentage is based on 3,245,270 shares outstanding as of March 24, 2026, and the reporting persons share voting and dispositive power over these shares, which are held by funds managed by Great Point.
How this was made
The 30-second read
Why it matters
This development could lead to increased share price due to perceived confidence, but is not guaranteed; market conditions and company fundamentals remain critical.
Market read
The stake disclosure is a positive signal for SLGL, suggesting institutional confidence, which may influence short to medium-term trading strategies.
What to watch
Market-wide downturns or sector-specific setbacks could negate the positive implications of the stake disclosure.
Background
The disclosure of an 8.45% stake by notable investors and institutions signals increased interest in SLGL, possibly ahead of upcoming catalysts or strategic moves.
Ticker impact
The disclosed 8.45% stake in Sol-Gel Technologies Ltd. (SLGL) indicates increased institutional interest, which could signal positive sentiment or strategic positioning.
Moderate upward price movement expected over the next 1-3 months.
Institutional holdings often precede positive catalysts, but the passive nature of the stake indicates limited immediate influence.
Market effects
Potentially bullish for the life sciences sector, especially companies involved in similar technologies.
Limited regional impact; primarily relevant to investors in the company's primary markets.
Moderate; reflects global investor interest in biotech/pharmaceutical innovations.
Counterpoint
The stake may be passive and not indicative of positive future performance; the stock could remain range-bound or decline.
Key entities
- Institutional InvestorGreat Point Partners, LLC
A private equity and venture capital firm with interests in biotech.
- InvestorDr. Jeffrey R. Jay
A notable investor with holdings in biotech firms.
- InvestorMs. Lillian Nordahl
A significant stakeholder in SLGL.



